APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diagnostic Reagent

Diagnostic Reagent is any reagent that is used in vitro or in vivo for detection or screening of a particular disease or any health-related issue.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Diagnostic Reagent is any reagent that is used in vitro or in vivo for detection or screening of a particular disease or any health-related issue.

Selected research

Market Outlook & Growth Opportunities

Global Diagnostic Reagent Market Outlook and Growth Opportunities 2026

21 December 2025209 pages

Choose your research edition.

Industry ResearchDiagnostic Reagent Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Diagnostic Reagent Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Diagnostic Reagent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diagnostic Reagent Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Diagnostic Reagent Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

Diagnostic Reagent is any reagent that is used in vitro or in vivo for detection or screening of a particular disease or any health-related issue.

Global Diagnostic Reagent key players include Roche, Siemens, Abbott, Danaher, Thermo Fisher, etc. Global top five manufacturers hold a share about 50%.

North America is the largest market, with a share about 45%, followed by West Europe and Japan, both have a share about 40 percent.

Read the full market overview

In terms of product, Immune diagnosis is the largest segment, with a share over 30%. And in terms of application, the largest application is Detection of Infectious Diseases, followed by Endocrine Examination and Immunoassay Method.

This report provides an overview of the global Diagnostic Reagent market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Diagnostic Reagent and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Diagnostic Reagent revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Diagnostic Reagent market.

Diagnostic Reagent Segment by Company

Roche

Siemens

Abbott

Danaher

Thermo Fisher

BioMerieux

Bio-Rad

BD

JNJ

Sysmex

KHB

DaAn Gene

Leadman

BioSino

BSBE

Maccura

Diagnostic Reagent Segment by Type

In Vivo Diagnostic Reagents

In Vitro Diagnostic Reagents

Diagnostic Reagent Segment by Application

Endocrine Examination

Tumor Detection

Detection of Infectious Diseases

Immunoassay Method

Cytokine Examination

Myocardial Infarction Detection

PCR

Eugenics Detection (TORCH)

Other

Diagnostic Reagent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Diagnostic Reagent status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Diagnostic Reagent key companies, revenue, market share, and recent developments.

3. To split the Diagnostic Reagent breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Diagnostic Reagent market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Diagnostic Reagent significant trends, drivers, influence factors in global and regions.

6. To analyze Diagnostic Reagent competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Reagent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Reagent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Reagent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Diagnostic Reagent industry.

Chapter 3: Detailed analysis of Diagnostic Reagent company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Diagnostic Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Diagnostic Reagent in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Diagnostic Reagent Industry Trends Table 2. Diagnostic Reagent Industry Drivers Table 3. Diagnostic Reagent Industry Opportunities and Challenges Table 4. Diagnostic Reagent Industry Restraints Table 5. Global Diagnostic Reagent Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Diagnostic Reagent Revenue Share by Company (2021-2026) Table 7. Global Diagnostic Reagent Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Diagnostic Reagent Key Company Manufacturing Base & Headquarters Table 9. Global Diagnostic Reagent Company, Product Type & Application Table 10. Global Diagnostic Reagent Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Diagnostic Reagent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of In Vivo Diagnostic Reagents Table 15. Significant Companies of In Vitro Diagnostic Reagents Table 16. Global Diagnostic Reagent Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Diagnostic Reagent Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Diagnostic Reagent Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Diagnostic Reagent Sales Value Share by Type (2021-2026) Table 20. Global Diagnostic Reagent Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Endocrine Examination Table 22. Significant Companies of Tumor Detection Table 23. Significant Companies of Detection of Infectious Diseases Table 24. Significant Companies of Immunoassay Method Table 25. Significant Companies of Cytokine Examination Table 26. Significant Companies of Myocardial Infarction Detection Table 27. Significant Companies of PCR Table 28. Significant Companies of Eugenics Detection (TORCH) Table 29. Significant Companies of Other Table 30. Global Diagnostic Reagent Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Diagnostic Reagent Sales Value by Application (2021-2026) & (US$ Million) Table 32. Global Diagnostic Reagent Sales Value by Application (2027-2032) & (US$ Million) Table 33. Global Diagnostic Reagent Sales Value Share by Application (2021-2026) Table 34. Global Diagnostic Reagent Sales Value Share by Application (2027-2032) Table 35. Global Diagnostic Reagent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Diagnostic Reagent Sales Value by Region (2021-2026) & (US$ Million) Table 37. Global Diagnostic Reagent Sales Value Share by Region (2021-2026) Table 38. Global Diagnostic Reagent Sales Value by Region (2027-2032) & (US$ Million) Table 39. Global Diagnostic Reagent Sales Value Share by Region (2027-2032) Table 40. Global Diagnostic Reagent Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Diagnostic Reagent Sales Value by Country (2021-2026) & (US$ Million) Table 42. Global Diagnostic Reagent Sales Value Market Share by Country (2021-2026) Table 43. Global Diagnostic Reagent Sales Value by Country (2027-2032) & (US$ Million) Table 44. Global Diagnostic Reagent Sales Value Market Share by Country (2027-2032) Table 45. Roche Company Information Table 46. Roche Business Overview Table 47. Roche Diagnostic Reagent Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Roche Diagnostic Reagent Product Portfolio Table 49. Roche Recent Development Table 50. Siemens Company Information Table 51. Siemens Business Overview Table 52. Siemens Diagnostic Reagent Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Siemens Diagnostic Reagent Product Portfolio Table 54. Siemens Recent Development Table 55. Abbott Company Information Table 56. Abbott Business Overview Table 57. Abbott Diagnostic Reagent Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Abbott Diagnostic Reagent Product Portfolio Table 59. Abbott Recent Development Table 60. Danaher Company Information Table 61. Danaher Business Overview Table 62. Danaher Diagnostic Reagent Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Danaher Diagnostic Reagent Product Portfolio Table 64. Danaher Recent Development Table 65. Thermo Fisher Company Information Table 66. Thermo Fisher Business Overview Table 67. Thermo Fisher Diagnostic Reagent Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Thermo Fisher Diagnostic Reagent Product Portfolio Table 69. Thermo Fisher Recent Development Table 70. BioMerieux Company Information Table 71. BioMerieux Business Overview Table 72. BioMerieux Diagnostic Reagent Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. BioMerieux Diagnostic Reagent Product Portfolio Table 74. BioMerieux Recent Development Table 75. Bio-Rad Company Information Table 76. Bio-Rad Business Overview Table 77. Bio-Rad Diagnostic Reagent Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Bio-Rad Diagnostic Reagent Product Portfolio Table 79. Bio-Rad Recent Development Table 80. BD Company Information Table 81. BD Business Overview Table 82. BD Diagnostic Reagent Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. BD Diagnostic Reagent Product Portfolio Table 84. BD Recent Development Table 85. JNJ Company Information Table 86. JNJ Business Overview Table 87. JNJ Diagnostic Reagent Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. JNJ Diagnostic Reagent Product Portfolio Table 89. JNJ Recent Development Table 90. Sysmex Company Information Table 91. Sysmex Business Overview Table 92. Sysmex Diagnostic Reagent Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Sysmex Diagnostic Reagent Product Portfolio Table 94. Sysmex Recent Development Table 95. KHB Company Information Table 96. KHB Business Overview Table 97. KHB Diagnostic Reagent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. KHB Diagnostic Reagent Product Portfolio Table 99. KHB Recent Development Table 100. DaAn Gene Company Information Table 101. DaAn Gene Business Overview Table 102. DaAn Gene Diagnostic Reagent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. DaAn Gene Diagnostic Reagent Product Portfolio Table 104. DaAn Gene Recent Development Table 105. Leadman Company Information Table 106. Leadman Business Overview Table 107. Leadman Diagnostic Reagent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Leadman Diagnostic Reagent Product Portfolio Table 109. Leadman Recent Development Table 110. BioSino Company Information Table 111. BioSino Business Overview Table 112. BioSino Diagnostic Reagent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. BioSino Diagnostic Reagent Product Portfolio Table 114. BioSino Recent Development Table 115. BSBE Company Information Table 116. BSBE Business Overview Table 117. BSBE Diagnostic Reagent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. BSBE Diagnostic Reagent Product Portfolio Table 119. BSBE Recent Development Table 120. Maccura Company Information Table 121. Maccura Business Overview Table 122. Maccura Diagnostic Reagent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Maccura Diagnostic Reagent Product Portfolio Table 124. Maccura Recent Development Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Diagnostic Reagent Product Image Figure 2. Global Diagnostic Reagent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diagnostic Reagent Market Size (2021-2032) & (US$ Million) Figure 4. Global Diagnostic Reagent Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. In Vivo Diagnostic Reagents Image Figure 8. In Vitro Diagnostic Reagents Image Figure 9. Global Diagnostic Reagent Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Diagnostic Reagent Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Diagnostic Reagent Sales Value Share by Type (2021-2032) Figure 12. Endocrine Examination Image Figure 13. Tumor Detection Image Figure 14. Detection of Infectious Diseases Image Figure 15. Immunoassay Method Image Figure 16. Cytokine Examination Image Figure 17. Myocardial Infarction Detection Image Figure 18. PCR Image Figure 19. Eugenics Detection (TORCH) Image Figure 20. Other Image Figure 21. Global Diagnostic Reagent Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Diagnostic Reagent Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global Diagnostic Reagent Sales Value Share by Application (2021-2032) Figure 24. Global Diagnostic Reagent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 25. Global Diagnostic Reagent Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 26. North America Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 27. North America Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Europe Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 29. Europe Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Asia-Pacific Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 32. South America Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 33. South America Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Middle East & Africa Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 36. USA Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. USA Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. USA Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Canada Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Canada Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Canada Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Mexico Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Mexico Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Mexico Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Germany Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Germany Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Germany Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. France Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. France Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. France Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. U.K. Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. U.K. Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. U.K. Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Italy Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Italy Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Italy Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Spain Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Spain Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Spain Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Russia Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Russia Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Russia Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Netherlands Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Netherlands Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Netherlands Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Nordic Countries Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Nordic Countries Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Nordic Countries Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. China Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. China Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. China Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Japan Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Japan Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Japan Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. South Korea Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. South Korea Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. South Korea Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. India Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. India Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. India Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Australia Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Australia Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Australia Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Southeast Asia Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Southeast Asia Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Southeast Asia Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Brazil Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Brazil Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Brazil Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Argentina Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Argentina Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Argentina Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Chile Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Chile Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Chile Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Colombia Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Colombia Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Colombia Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Peru Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Peru Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Peru Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Saudi Arabia Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Saudi Arabia Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Israel Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Israel Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Israel Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. UAE Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. UAE Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. UAE Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Turkey Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Turkey Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Turkey Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Iran Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Iran Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Iran Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Egypt Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Egypt Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Egypt Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Years Considered Figure 121. Research Process Figure 122. Key Executives Interviewed

Scope & coverage.

Types
  • In Vivo Diagnostic Reagents
  • In Vitro Diagnostic Reagents
Applications
  • Endocrine Examination
  • Tumor Detection
  • Detection of Infectious Diseases
  • Immunoassay Method
  • Cytokine Examination
  • Myocardial Infarction Detection
  • PCR
  • Eugenics Detection (TORCH)
  • Other
Companies covered
  • Roche
  • Siemens
  • Abbott
  • Danaher
  • Thermo Fisher
  • BioMerieux
  • Bio-Rad
  • BD
  • JNJ
  • Sysmex
  • KHB
  • DaAn Gene
  • Leadman
  • BioSino
  • BSBE
  • Maccura

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Diagnostic Reagent Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Diagnostic Reagent Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Diagnostic Reagent Market Dynamics
  1. 2.1 Diagnostic Reagent Industry Trends
  2. 2.2 Diagnostic Reagent Industry Drivers
  3. 2.3 Diagnostic Reagent Industry Opportunities and Challenges
  4. 2.4 Diagnostic Reagent Industry Restraints
3 Diagnostic Reagent Market by Company
  1. 3.1 Global Diagnostic Reagent Company Revenue Ranking in 2025
  2. 3.2 Global Diagnostic Reagent Revenue by Company (2021-2026)
  3. 3.3 Global Diagnostic Reagent Company Ranking (2024-2026)
  4. 3.4 Global Diagnostic Reagent Company Manufacturing Base and Headquarters
  5. 3.5 Global Diagnostic Reagent Company Product Type and Application
  6. 3.6 Global Diagnostic Reagent Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Diagnostic Reagent Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Diagnostic Reagent Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Diagnostic Reagent Market by Type
  1. 4.1 Diagnostic Reagent Type Introduction
  2. 4.1.1 In Vivo Diagnostic Reagents
  3. 4.1.2 In Vitro Diagnostic Reagents
  4. 4.2 Global Diagnostic Reagent Sales Value by Type
  5. 4.2.1 Global Diagnostic Reagent Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Diagnostic Reagent Sales Value by Type (2021-2032)
  7. 4.2.3 Global Diagnostic Reagent Sales Value Share by Type (2021-2032)
5 Diagnostic Reagent Market by Application
  1. 5.1 Diagnostic Reagent Application Introduction
  2. 5.1.1 Endocrine Examination
  3. 5.1.2 Tumor Detection
  4. 5.1.3 Detection of Infectious Diseases
  5. 5.1.4 Immunoassay Method
  6. 5.1.5 Cytokine Examination
  7. 5.1.6 Myocardial Infarction Detection
  8. 5.1.7 PCR
  9. 5.1.8 Eugenics Detection (TORCH)
  10. 5.1.9 Other
  11. 5.2 Global Diagnostic Reagent Sales Value by Application
  12. 5.2.1 Global Diagnostic Reagent Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.2.2 Global Diagnostic Reagent Sales Value by Application (2021-2032)
  14. 5.2.3 Global Diagnostic Reagent Sales Value Share by Application (2021-2032)
6 Diagnostic Reagent Regional Value Analysis
  1. 6.1 Global Diagnostic Reagent Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Diagnostic Reagent Sales Value by Region (2021-2032)
  3. 6.2.1 Global Diagnostic Reagent Sales Value by Region: 2021-2026
  4. 6.2.2 Global Diagnostic Reagent Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Diagnostic Reagent Sales Value (2021-2032)
  7. 6.3.2 North America Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Diagnostic Reagent Sales Value (2021-2032)
  10. 6.4.2 Europe Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Diagnostic Reagent Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Diagnostic Reagent Sales Value (2021-2032)
  16. 6.6.2 South America Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Diagnostic Reagent Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
7 Diagnostic Reagent Country-level Value Analysis
  1. 7.1 Global Diagnostic Reagent Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Diagnostic Reagent Sales Value by Country (2021-2032)
  3. 7.2.1 Global Diagnostic Reagent Sales Value by Country (2021-2026)
  4. 7.2.2 Global Diagnostic Reagent Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche Diagnostic Reagent Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Siemens
  8. 8.2.1 Siemens Company Information
  9. 8.2.2 Siemens Business Overview
  10. 8.2.3 Siemens Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Siemens Diagnostic Reagent Product Portfolio
  12. 8.2.5 Siemens Recent Developments
  13. 8.3 Abbott
  14. 8.3.1 Abbott Company Information
  15. 8.3.2 Abbott Business Overview
  16. 8.3.3 Abbott Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Abbott Diagnostic Reagent Product Portfolio
  18. 8.3.5 Abbott Recent Developments
  19. 8.4 Danaher
  20. 8.4.1 Danaher Company Information
  21. 8.4.2 Danaher Business Overview
  22. 8.4.3 Danaher Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Danaher Diagnostic Reagent Product Portfolio
  24. 8.4.5 Danaher Recent Developments
  25. 8.5 Thermo Fisher
  26. 8.5.1 Thermo Fisher Company Information
  27. 8.5.2 Thermo Fisher Business Overview
  28. 8.5.3 Thermo Fisher Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Thermo Fisher Diagnostic Reagent Product Portfolio
  30. 8.5.5 Thermo Fisher Recent Developments
  31. 8.6 BioMerieux
  32. 8.6.1 BioMerieux Company Information
  33. 8.6.2 BioMerieux Business Overview
  34. 8.6.3 BioMerieux Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BioMerieux Diagnostic Reagent Product Portfolio
  36. 8.6.5 BioMerieux Recent Developments
  37. 8.7 Bio-Rad
  38. 8.7.1 Bio-Rad Company Information
  39. 8.7.2 Bio-Rad Business Overview
  40. 8.7.3 Bio-Rad Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bio-Rad Diagnostic Reagent Product Portfolio
  42. 8.7.5 Bio-Rad Recent Developments
  43. 8.8 BD
  44. 8.8.1 BD Company Information
  45. 8.8.2 BD Business Overview
  46. 8.8.3 BD Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BD Diagnostic Reagent Product Portfolio
  48. 8.8.5 BD Recent Developments
  49. 8.9 JNJ
  50. 8.9.1 JNJ Company Information
  51. 8.9.2 JNJ Business Overview
  52. 8.9.3 JNJ Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  53. 8.9.4 JNJ Diagnostic Reagent Product Portfolio
  54. 8.9.5 JNJ Recent Developments
  55. 8.10 Sysmex
  56. 8.10.1 Sysmex Company Information
  57. 8.10.2 Sysmex Business Overview
  58. 8.10.3 Sysmex Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sysmex Diagnostic Reagent Product Portfolio
  60. 8.10.5 Sysmex Recent Developments
  61. 8.11 KHB
  62. 8.11.1 KHB Company Information
  63. 8.11.2 KHB Business Overview
  64. 8.11.3 KHB Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  65. 8.11.4 KHB Diagnostic Reagent Product Portfolio
  66. 8.11.5 KHB Recent Developments
  67. 8.12 DaAn Gene
  68. 8.12.1 DaAn Gene Company Information
  69. 8.12.2 DaAn Gene Business Overview
  70. 8.12.3 DaAn Gene Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  71. 8.12.4 DaAn Gene Diagnostic Reagent Product Portfolio
  72. 8.12.5 DaAn Gene Recent Developments
  73. 8.13 Leadman
  74. 8.13.1 Leadman Company Information
  75. 8.13.2 Leadman Business Overview
  76. 8.13.3 Leadman Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Leadman Diagnostic Reagent Product Portfolio
  78. 8.13.5 Leadman Recent Developments
  79. 8.14 BioSino
  80. 8.14.1 BioSino Company Information
  81. 8.14.2 BioSino Business Overview
  82. 8.14.3 BioSino Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BioSino Diagnostic Reagent Product Portfolio
  84. 8.14.5 BioSino Recent Developments
  85. 8.15 BSBE
  86. 8.15.1 BSBE Company Information
  87. 8.15.2 BSBE Business Overview
  88. 8.15.3 BSBE Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  89. 8.15.4 BSBE Diagnostic Reagent Product Portfolio
  90. 8.15.5 BSBE Recent Developments
  91. 8.16 Maccura
  92. 8.16.1 Maccura Company Information
  93. 8.16.2 Maccura Business Overview
  94. 8.16.3 Maccura Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Maccura Diagnostic Reagent Product Portfolio
  96. 8.16.5 Maccura Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst